NEW YORK (AP) — On Thursday, the U.S. Department of Health and Human Services (HHS) unveiled a new strategy to enhance the implementation of artificial intelligence (AI) within its operations. This plan builds upon the prior administration’s enthusiasm for AI technology but also highlights significant concerns regarding the protection of sensitive health information.
HHS characterized the initiative as a first step toward increasing efficiency and promoting AI innovation across its divisions. The 20-page strategy document outlines ambitious goals such as analyzing patient health data and advancing drug development.
“For too long, our Department has been bogged down by bureaucracy and busy-work,” stated Deputy HHS Secretary Jim O’Neill. “It is time to tear down these barriers to progress and unite in our use of technology to Make America Healthy Again.”
The strategy encourages a culture of experimentation with AI, suggesting that employees utilize tools like ChatGPT to enhance productivity. While the administration embraces AI innovation, experts warn about the associated risks, especially concerning data privacy and the handling of sensitive patient information.
Oren Etzioni, an AI expert, expressed cautious optimism regarding the HHS strategy but highlighted a need for rigorous standards to protect health data. Concerns have been raised about whether HHS can adequately address these issues, especially under the leadership of Health Secretary Robert F. Kennedy Jr., who has faced scrutiny regarding his scientific rigor.
Experts question how the new strategy will ensure the protection of sensitive medical data amid promises for improved data infrastructure and rapid AI deployment. While HHS projects an increase in AI implementations, doubts linger about balancing innovation with privacy.
Despite the challenges, the HHS suggests that their AI strategy could lead to transformative changes, marking a significant modernization of agency operations.
